In vitro dose effect relationships of actinium-225- and lutetium-177-labeled PSMA-I&T.

Purpose: Targeting the prostate-specific membrane antigen (PSMA) using lutetium-177-labeled PSMA-specific tracers has become a very promising novel therapy option for prostate cancer (PCa). The efficacy of this therapy might be further improved by replacing the β-emitting lutetium-177 with the α-emi...

Descripción completa

Detalles Bibliográficos

Publicado en:	European Journal of Nuclear Medicine & Molecular Imaging Vol. 49; no. 11; pp. 3627 - 3639
Autores principales:	Ruigrok, Eline A. M., Tamborino, Giulia, de Blois, Erik, Roobol, Stefan J., Verkaik, Nicole, De Saint-Hubert, Marijke, Konijnenberg, Mark W., van Weerden, Wytske M., de Jong, Marion, Nonnekens, Julie
Formato:	Journal Article
Publicado:	Springer Nature Sep2022
Acceso en línea:	Ver este registro en EBSCOhost